164 related articles for article (PubMed ID: 19077144)
1. MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters.
Höiom V; Tuominen R; Käller M; Lindén D; Ahmadian A; Månsson-Brahme E; Egyhazi S; Sjöberg K; Lundeberg J; Hansson J
Pigment Cell Melanoma Res; 2009 Apr; 22(2):196-204. PubMed ID: 19077144
[TBL] [Abstract][Full Text] [Related]
2. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
[TBL] [Abstract][Full Text] [Related]
3. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
4. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
5. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
6. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
7. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?
Palmer JS; Duffy DL; Box NF; Aitken JF; O'Gorman LE; Green AC; Hayward NK; Martin NG; Sturm RA
Am J Hum Genet; 2000 Jan; 66(1):176-86. PubMed ID: 10631149
[TBL] [Abstract][Full Text] [Related]
8. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
Chaudru V; Laud K; Avril MF; Minière A; Chompret A; Bressac-de Paillerets B; Demenais F
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2384-90. PubMed ID: 16214921
[TBL] [Abstract][Full Text] [Related]
9. MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project.
Caini S; Gandini S; Botta F; Tagliabue E; Raimondi S; Nagore E; Zanna I; Maisonneuve P; Newton-Bishop J; Polsky D; Lazovich D; Kumar R; Kanetsky PA; Hoiom V; Ghiorzo P; Landi MT; Ribas G; Menin C; Stratigos AJ; Palmieri G; Guida G; García-Borrón JC; Nan H; Little J; Sera F; Puig S; Fargnoli MC;
Melanoma Res; 2020 Oct; 30(5):500-510. PubMed ID: 32898390
[TBL] [Abstract][Full Text] [Related]
10. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis.
Ibarrola-Villava M; Hu HH; Guedj M; Fernandez LP; Descamps V; Basset-Seguin N; Bagot M; Benssussan A; Saiag P; Fargnoli MC; Peris K; Aviles JA; Lluch A; Ribas G; Soufir N
Eur J Cancer; 2012 Sep; 48(14):2183-91. PubMed ID: 22464347
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
[TBL] [Abstract][Full Text] [Related]
12. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.
Ibarrola-Villava M; Fernandez LP; Pita G; Bravo J; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
Exp Dermatol; 2010 Sep; 19(9):836-44. PubMed ID: 20629734
[TBL] [Abstract][Full Text] [Related]
14. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.
Bastiaens MT; ter Huurne JA; Kielich C; Gruis NA; Westendorp RG; Vermeer BJ; Bavinck JN;
Am J Hum Genet; 2001 Apr; 68(4):884-94. PubMed ID: 11254446
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.
Huerta C; Garcia-Casado Z; Bañuls J; Moragon M; Oliver V; Unamuno B; Requena C; Kumar R; Nagore E
Acta Derm Venereol; 2018 Apr; 98(5):512-516. PubMed ID: 29405243
[TBL] [Abstract][Full Text] [Related]
16. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
[TBL] [Abstract][Full Text] [Related]
17. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.
Box NF; Duffy DL; Chen W; Stark M; Martin NG; Sturm RA; Hayward NK
Am J Hum Genet; 2001 Oct; 69(4):765-73. PubMed ID: 11500805
[TBL] [Abstract][Full Text] [Related]
18. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
[TBL] [Abstract][Full Text] [Related]
19. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
[TBL] [Abstract][Full Text] [Related]
20. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
